Cold & Cough, High Blood Pressure Relief - Compare to Coricidin®
Brand: Major Pharmaceuticals
USD 1.95 — In stock
How to order
In stock — USD 1.95.
Prefer to order with a person? +1 855 932 4721 · info@priconmed.com · Contact us.
Variants
- & Cough, High Blood Pressure , 16s, Compare to Coricidin®, NDC# 00904-6634-44 — USD 1.95 — In stock — SKU 873602
Product intelligence — AI-assisted — defer to the manufacturer's IFU
01 — At a glance
Product overview
Major Pharmaceuticals Cold & Cough Tablets are over-the-counter medications designed for the symptomatic relief of respiratory congestion and coughing. Specifically formulated for patients with high blood pressure, these tablets serve as a generic alternative for clinics and outpatient facilities seeking cost-effective cough and cold management.
- Brand
- Major Pharmaceuticals
- Product Type
- Cough/Cold/Allergy
- Active Ingredient Strength
- Guaifenesin 200mg (select variants)
- NDC Numbers
- 00904-6634-44, 00904-5154-60, 00904-5786-24
- Packaging
- 16s, 24s, or 100s depending on variant
- Case Quantity
- 24 bottles per case (Guaifenesin variant)
How to think about this product
When selecting between these variants, procurement staff should consider the specific patient population, particularly focusing on the High Blood Pressure relief option for patients requiring decongestant-free formulas. The product line offers various strengths and active ingredient combinations, ranging from single-ingredient expectorants to multi-symptom relief tablets. These tablets are provided in standard retail-style bottle counts and case quantities suitable for pharmacy dispensing or outpatient clinic supply rooms.
02 — Clinical applications
Where this product is used
Cold & Cough, High Blood Pressure Relief - Compare to Coricidin® is commonly used in:
- Symptomatic cough relief for hypertensive patients
- Expectorant therapy for productive cough management
- Multi-symptom cold relief in urgent care clinics
- Over-the-counter respiratory treatment in occupational health
03 — People also ask
Frequently asked questions
Q01 Who manufactures Cold & Cough, High Blood Pressure Relief - Compare to Coricidin®?
Cold & Cough, High Blood Pressure Relief - Compare to Coricidin® is manufactured by Major Pharmaceuticals. PriconMed sources this item through authorized supply channels so the lot, packaging, and expiration date match what Major Pharmaceuticals ships from the factory.
Q02 Is bulk or contract pricing available?
Yes. Verified facilities ordering full cases of Cold & Cough, High Blood Pressure Relief - Compare to Coricidin® — or building a standing order — can request a custom quote from our wholesale team and qualify for tiered pricing and net-30 terms.
Q03 How quickly does this ship?
In-stock orders for Cold & Cough, High Blood Pressure Relief - Compare to Coricidin® are handled at our St. Louis Park, Minnesota warehouse in 0–5 business days (3 PM CST cutoff) and arrive in 3–11 business days total, including 3–6 business days in transit. Ground shipping is a flat $9.99 and free on orders of $250 or more. You'll see the live in-stock count on this page; if the item is low, contact us for an ETA before placing a large order.
Q04 Can I return this product if it doesn't work for my facility?
Unopened, in-date medical supplies in original packaging can be returned within 60 days — return by mail with a free downloadable label, restocking fee $0 (none), and refunds are processed within 5 days of receipt. Sterile or opened items cannot be returned for infection-control reasons. See our Returns policy for the full process.
Q05 Is this HSA/FSA eligible?
Most medical supplies sold by PriconMed — including Cough/Cold/Allergy — are eligible for purchase with HSA and FSA funds when used for a qualifying medical condition. Save your PriconMed invoice for reimbursement.
04 — Wholesale · For verified medical professionals
Need a bulk quote?
Ordering 5+ cases or stocking a facility? Our wholesale team can offer custom pricing, standing orders, and net-30 terms.
- Net-30 terms
- Custom pricing
- 1 business day response